Compare BRNS & JAGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRNS | JAGU |
|---|---|---|
| Founded | 2016 | 2022 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9M | 63.2M |
| IPO Year | 2021 | N/A |
| Metric | BRNS | JAGU |
|---|---|---|
| Price | $0.55 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 33.5K | ★ 514.1K |
| Earning Date | 03-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $1.44 |
| 52 Week High | $2.91 | $3.60 |
| Indicator | BRNS | JAGU |
|---|---|---|
| Relative Strength Index (RSI) | 35.70 | 42.70 |
| Support Level | N/A | $1.46 |
| Resistance Level | $0.76 | $3.49 |
| Average True Range (ATR) | 0.04 | 0.26 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 16.67 | 84.75 |
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.